By the unsupervised hierarchy clustering analysis on glycogenes, our previous study has identified ST3GAL6 as a poor prognostic biomarker in bladder cancer (Dalangood et al., 2020), suggesting that we can identify key drivers from glycogenes for tumor aggressiveness. This evidence concerns the gene ST3GAL6 and urinary bladder cancer.